Long-acting integrase inhibitor protects macaques from intrarectal simian/human immunodeficiency virus.
about
Multifunctional facets of retrovirus integrasePre-exposure prophylaxis to prevent HIV infection: current status, future opportunities and challengesPreventing HIV infection: pre-exposure and postexposure prophylaxisNanoformulations of Rilpivirine for Topical Pericoital and Systemic Coitus-Independent Administration Efficiently Prevent HIV TransmissionApproved Antiviral Drugs over the Past 50 YearsProfile of cabotegravir and its potential in the treatment and prevention of HIV-1 infection: evidence to dateAntiretrovirals for primary HIV prevention: the current status of pre- and post-exposure prophylaxisEnding the global HIV/AIDS pandemic: the critical role of an HIV vaccine.Implementation challenges for long-acting antivirals as treatment.Engineered Bispecific Antibodies with Exquisite HIV-1-Neutralizing Activity.High interest in a long-acting injectable formulation of pre-exposure prophylaxis for HIV in young men who have sex with men in NYC: a P18 cohort substudyDolutegravir, the Second-Generation of Integrase Strand Transfer Inhibitors (INSTIs) for the Treatment of HIV.Pharmacokinetics of injectable, long-acting nevirapine for HIV prophylaxis in breastfeeding infants.Using geospatial modelling to optimize the rollout of antiretroviral-based pre-exposure HIV interventions in Sub-Saharan AfricaThe role of dolutegravir in the management of HIV infectionPharmacokinetic profile of raltegravir, elvitegravir and dolutegravir in plasma and mucosal secretions in rhesus macaquesClinical Treatment Options Infectious Diseases: Update on PrEP Implementation, Adherence, and Advances in DeliveryGSK1265744 demonstrates robust in vitro activity against various clades of HIV-1.A long-acting integrase inhibitor protects female macaques from repeated high-dose intravaginal SHIV challenge.Neutralization properties of simian immunodeficiency viruses infecting chimpanzees and gorillas.Pharmacokinetics of antiretrovirals in mucosal tissueA new hypothesis on HIV cure.Characterization of the Drug Resistance Profiles of Integrase Strand Transfer Inhibitors in Simian Immunodeficiency Virus SIVmac239.A Shot in the Arm for HIV Prevention? Recent Successes and Critical Thresholds.The mixed lineage kinase-3 inhibitor URMC-099 improves therapeutic outcomes for long-acting antiretroviral therapyThe promise and pitfalls of long-acting injectable agents for HIV prevention.Potential Clinical and Economic Value of Long-Acting Preexposure Prophylaxis for South African Women at High-Risk for HIV Infection.A long-acting formulation of the integrase inhibitor raltegravir protects humanized BLT mice from repeated high-dose vaginal HIV challenges.Topical Tenofovir Disoproxil Fumarate Nanoparticles Prevent HIV-1 Vaginal Transmission in a Humanized Mouse ModelDrug delivery strategies and systems for HIV/AIDS pre-exposure prophylaxis and treatment.Familiarity with and Preferences for Oral and Long-Acting Injectable HIV Pre-exposure Prophylaxis (PrEP) in a National Sample of Gay and Bisexual Men in the U.S.Regulatory considerations for antiretroviral prophylaxis to prevent HIV acquisition.Nanoformulation strategies for the enhanced oral bioavailability of antiretroviral therapeutics.Formulation and pharmacology of long-acting cabotegravir.Down-regulation of human endogenous retrovirus type K (HERV-K) viral env RNA in pancreatic cancer cells decreases cell proliferation and tumor growth.The future of pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) infection.Long-Acting Antiretrovirals: Where Are We now?Optimal HIV Postexposure Prophylaxis Regimen Completion With Single Tablet Daily Elvitegravir/Cobicistat/Tenofovir Disoproxil Fumarate/Emtricitabine Compared With More Frequent Dosing Regimens.Tackling HIV and AIDS: contributions by non-human primate models.Cabotegravir long acting injection protects macaques against intravenous challenge with SIVmac251.
P2860
Q26795766-D9CAAAF9-4D5C-4FFF-A9D9-19665CE9FD9DQ26825641-EA67D571-9F3C-4765-93B2-46EB2C49C252Q26828445-C5FF8DAD-2DC8-419E-AA45-B3556E1B19F4Q27318354-FA844143-B1F2-4A0E-BD75-6F1F972B90AAQ27755387-26F3F704-96A6-429B-B201-6D4EC15D253DQ28079025-68FCD8F2-442F-4116-8908-7781CE33FAE2Q28085433-F85C2029-E1B1-45E9-BEF5-132BC16BFF32Q30365998-0DEE309A-AE17-4826-B04B-72CE44AAE056Q30375397-207CD24B-0F73-4713-AF70-93513CDF3EBFQ34531219-4D5BBD73-1AE4-483D-91AD-E07AB0C701EDQ34681829-9F2C3E58-C0AD-455A-9E31-4B1548083F28Q34726183-1BB5BB20-FA69-4DD1-8EF8-FD74909F0EFAQ34922985-55A88F93-A2DC-4BA8-9469-D248A1E26ED9Q35067756-4BA4C6EF-B696-4994-BA77-2191540540B2Q35121450-9D225FC0-2502-4090-8E02-56F9D797F6C4Q35432739-9FEEB1AD-AA09-429A-A472-7B0848F94A61Q35541521-F55FDF46-832F-46FA-A7FD-31574D4A8B0EQ35629509-348948C4-47CB-491A-BF33-B24CCB2F7517Q35667426-C2D4AE15-444D-4AF8-985B-A0F383F97C8BQ35677620-0CB7A54A-215E-4F13-BBFF-54B0FC57EA11Q35838594-BD69F845-0D87-4414-B33F-FA1C3529B59DQ36028475-90AEB4D0-96F4-48FF-A570-D6BFE5840C76Q36281109-82A1FDDC-1462-4A50-B044-97E73663CF94Q36294782-169EBCFE-0B76-4196-8D07-9D91AFB2A70CQ36505647-8D98A8DD-EF5D-4E19-829F-59281DE6221FQ36561375-BC15994F-DE6D-4F4F-815B-C1ECF1D1386DQ36816564-D3EC72BE-8AB5-4718-A9B8-58E7C2BB7B15Q36901505-B601BFFF-6644-4CB5-9A03-5CE5A80BE60CQ36933427-4C211BED-C448-4966-9166-008D9C44DADDQ36934918-8F5E18B9-A69A-417E-BE37-21B6B3824D9DQ36995428-4095FA72-73A5-4E2D-8D6C-7A08616E30CBQ38233289-8758FDF8-7042-430B-92FB-69C4C2B0AAB8Q38495022-27FAB000-9A17-4F55-8606-177C4F1C9175Q38518434-6EE527F3-2A1E-429A-A6D8-FA59E404C570Q38692314-B918E4C0-B19B-4B44-8ECF-1CC2EAECD99DQ38742497-D18C560E-0F22-4E89-A2A9-0233B05957C1Q38902077-2E3FF56A-D18F-4A6F-8F54-7422FA3EE9B9Q40127599-E9B8B90B-7486-450C-A07E-2130A5051137Q40191155-5E5664B0-AA8C-4A8F-8DE4-CA7C3CF607F6Q40429647-E0364662-5E33-4FE1-A5F3-0B2D5DE3C7D1
P2860
Long-acting integrase inhibitor protects macaques from intrarectal simian/human immunodeficiency virus.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Long-acting integrase inhibito ...... /human immunodeficiency virus.
@ast
Long-acting integrase inhibito ...... /human immunodeficiency virus.
@en
type
label
Long-acting integrase inhibito ...... /human immunodeficiency virus.
@ast
Long-acting integrase inhibito ...... /human immunodeficiency virus.
@en
prefLabel
Long-acting integrase inhibito ...... /human immunodeficiency virus.
@ast
Long-acting integrase inhibito ...... /human immunodeficiency virus.
@en
P2093
P2860
P356
P1433
P1476
Long-acting integrase inhibito ...... n/human immunodeficiency virus
@en
P2093
Agegnehu Gettie
Cecilia Cheng-Mayer
Chasity D Andrews
David D Ho
Hiroshi Mohri
Martin Markowitz
Rudolf P Bohm
Susan Ford
William R Spreen
P2860
P304
P356
10.1126/SCIENCE.1248707
P407
P577
2014-03-04T00:00:00Z